Tampere University
Tampere, Finland
NCT Number: NCT07676227
The purpose of this study is to gather measurement data for the development and testing of a wearable patient monitor's pulse oximeter. The PaMo patient monitor measures respiratory rate, blood oxygen saturation, and electrocardiogram (ECG). The device transmits data via Bluetooth to a mobile application for immediate interpretation. The device, developed at Tampere University, aims to provide a wireless solution for monitoring patients' breathing and circulation, especially after surgical procedures. The collected data will be used to demonstrate the device's oxygen saturation measurement capability according to the European ISO 80601-2-61:2019 standard, contributing to further refinement of the solution.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Tampere, Finland
The study involves controlled desaturation for voluntary participants, gradually lowering blood oxygen levels by reducing the inhaled air's oxygen content. This reduction is facilitated by the Hypoxico device, simulating high-altitude conditions. The device, connected to a transparent tent placed over subject's upper body, gradually decreases the surrounding air's oxygen content. Oxygen saturation is lowered to a minimum of 70%, and the measurement period lasts a maximum of 30 minutes. A physician and two research team members will be present throughout the measurement. Vital signs, including respiratory rate, heart's electrical activity, blood pressure, and oxygen saturation, will be monitored using the patient monitor in addition to the device being studied. Carbon dioxide levels in exhaled breath will be measured using nasal cannulas.
Reference devices:
Masimo RAD-97 pulse oximeter is a class IIB device and leading technology in measuring SpO2 and has demonstrated high sensitivity and accuracy even during conditions of motion and low perfusion. SpO2 and pulse will be monitored during the measurement period.
GE Carescape B450 is a class IIB device and globally used patient monitor with highly sophisticated algorithms for arrhythmia, non-invasive blood pressure and SpO2. 5-digit ECG, non-invasive blood pressure, IP, SpO2 and pulse will be monitored during the measurement period.
The study does not include a control group. All subjects are using the devices in similar way and the parameters collected from the same individual using two different methods are compared.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Controlled hypoxia induced with Hypoxico device
Time frame: Continuous measurement up to 30 minutes
Average root mean square (ARMS) difference compared with reference device
Time frame: Continuous measurement up to 30 minutes
SpO2 ≤92%
Tampere University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06077851
Clinical Deterioration, Disease Attributes
Copenhagen, NV, Denmark
View Trial DetailsNCT07057440
ECG, Heart Rate
Hvidovre, Denmark
View Trial DetailsNCT06816420
Catheter Placement and Perceived Pain, Neurologic Manifestations
Konya, Meram, Turkey (Türkiye)
View Trial DetailsNCT05536206
Clinical Deterioration, Disease Attributes
Copenhagen, NV, Denmark
View Trial Details